Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1970-6-5
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0037-9727
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
133
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1310-3
|
| pubmed:dateRevised |
2007-11-2
|
| pubmed:meshHeading |
pubmed-meshheading:5440420-Animals,
pubmed-meshheading:5440420-Dogs,
pubmed-meshheading:5440420-Drug Antagonism,
pubmed-meshheading:5440420-Hydroxyindoleacetic Acid,
pubmed-meshheading:5440420-Male,
pubmed-meshheading:5440420-Pargyline,
pubmed-meshheading:5440420-Phenylacetates,
pubmed-meshheading:5440420-Probenecid
|
| pubmed:year |
1970
|
| pubmed:articleTitle |
Homovanillic and 5-hydroxyindoleacetic acids in cerebrospinal fluid after probenecid: measurement of brain monoamine oxidase inhibition in vivo.
|
| pubmed:publicationType |
Journal Article
|